The Post-Market Security Landscape

Post-market security for medical devices means continuous vulnerability monitoring, risk assessment, patching, and stakeholder communication for the life of the device, with manufacturers, healthcare facilities, users, and FDA each carrying part of the load. The expectations come primarily from FDA's 2016 postmarket guidance and, for cyber devices, Section 524B of the FD&C Act.

5.2.1 FDA's Expectations

According to FDA's 2016 Post-market Cybersecurity Guidance, manufacturers must:

• Continuously monitor for vulnerabilities
• Assess and respond to risks
• Communicate with stakeholders
• Maintain device security

The 2023 guidance reinforces these expectations, particularly for devices under Section 524B, which legally requires a cybersecurity management plan including post-market activities.

The stakes keep rising. Large healthcare data breaches reported to the HHS Office for Civil Rights affected well over 100 million people in 2023 alone, most of them through hacking and IT incidents. Connected medical devices sit inside that same threat environment.

5.2.2 The Shared Responsibility Model

Post-market cybersecurity is a team sport:

Manufacturers (You):

• Monitor for vulnerabilities
• Develop patches
• Communicate risks
• Provide updates

Healthcare Facilities:

• Apply updates
• Maintain secure networks
• Monitor devices
• Report issues

Users:

• Follow security procedures
• Report suspicious activity
• Apply updates when notified

FDA:

• Provide guidance
• Monitor safety signals
• Coordinate responses
• Enforce requirements

5.2.3 The Threat Timeline

Understanding how threats evolve helps prioritize responses:

flowchart LR
    A[Day 0: Vulnerability Exists] --> B[Discovery]
    B --> C{By Whom?}
    C -->|Researcher| D[Responsible Disclosure]
    C -->|Attacker| E[Zero-Day Exploit]
    D --> F[Patch Development]
    E --> G[Active Exploitation]
    F --> H[Patch Release]
    G --> I[Incident Response]
    H --> J[Customer Deployment]
    I --> K[Emergency Patching]